Nuclear Medicine and Molecular Imaging Essentials

Key Features

Fulfills Nuclear Medicine/PET CME requirements. 15.5 AMA PRA Category I Credits™, including several Nuclear Cardiology topics.

Topics Covered

• Nuclear Cardiology
• Neuro
• Body Imaging
• Safety Precautions
• Practice Enhancements

Learning Objectives

Following this continuing medical education activity, the participant should be able to:

• Discuss the importance of Partial Volume Effect (PVE) in designing and testing new radiotracers for both research and clinical applications.
• Describe the various PET radiopharmaceuticals that play a role in thyroid imaging.
• Compare Nuclear Medicine diagnostic outcomes with radiographic and/or other diagnostic procedures.
• Utilize Cardiac PET to optimal laboratory performance.
• Describe the role and limitations of PSMA PET-CT.
• Discuss the uses of [F18]-fluorodeoxyglucose in patients with cognitive decline/dementia.

Target Audience

This activity is designed for nuclear medicine physicians, technologists, radiologists, neurologists, oncologists, cardiologists and other medical professionals who use radionuclides in the care of patients.

Additional credit info

Release Date: 5/15/17

CME Expiration: 5/14/20

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Global Education Group (Global) and Meetings By Mail. Global is accredited by the ACCME to provide continuing medical education for physicians.

Global Education Group designates this enduring material for a maximum of 15.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All credits for this enduring material are applicable toward Self Assessment CME requirements for Maintenance of Certification (MOC).